MICHAEL J SEVILLA
Allopathic & Osteopathic Physicians|Family Medicine SALEM, OH NPI 1114032901
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine OH Seqirus USA Inc All categories
General Payments — all program years on this page
$5,813.46
- Category: General Payments
- Program years: PY2018–2024
- Record count: 307
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,485.31 across 39 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $834.00 | 1 |
| Food and Beverage | $651.31 | 38 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Seqirus USA Inc | $862.49 | 3 |
| Acerta Pharma LLC | $73.48 | 5 |
| Novo Nordisk AS | $56.50 | 3 |
| Sumitomo Pharma America, Inc. | $56.35 | 3 |
| Antares Pharma, Inc. | $49.75 | 2 |
| Merck Sharp & Dohme Corporation | $48.85 | 3 |
| Abbott Laboratories | $45.68 | 3 |
| Lilly USA, LLC | $41.91 | 2 |
| PFIZER INC. | $37.50 | 2 |
| ABBVIE INC. | $35.47 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $32.31 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.92 | 2 |
| Astellas Pharma US Inc | $29.01 | 2 |
| Corcept Therapeutics | $25.14 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.99 | 1 |
| Amgen Inc. | $14.52 | 1 |
| GlaxoSmithKline, LLC. | $13.76 | 1 |
| Azurity Pharmaceuticals, Inc. | $13.68 | 1 |
By program year
Records — PY2024 (39)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.